Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion type Assertion NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_head.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion description "[Low activity of arylamine N-acetyltransferase 2 (slow NAT2) was consistently associated with urinary bladder cancer risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_provenance.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion evidence source_evidence_literature NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_provenance.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion SIO_000772 10022251 NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_provenance.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion wasDerivedFrom befree-2016 NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_provenance.
- NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_assertion wasGeneratedBy ECO_0000203 NP245625.RAE11lw2T5wETzJfGDAY4rEAfT9EtJB8cSU5IqIVmQE-E130_provenance.